The clinical and genetic spectrum of catecholaminergic polymorphic ventricular tachycardia: findings from an international multicentre registry

M. Roston, Thomas; Yuchi, Zhiguang; J. Kannankeril, Prince; Hathaway, Julie; M. Vinocur, Jeffrey; P. Etheridge, Susan; E. Potts, James; R. Maginot, Kathleen; C. Salerno, Jack; I. Cohen, Mitchell; M. Hamilton, Robert; Pflaumer, Andreas; Mohammed, Saira; Kimlicka, Lynn; J. Kanter, Ronald; J. LaPage, Martin; K. Collins, Kathryn; Gebauer, Roman; Temple, Joel; S. Batra, Anjan; Erickson, Christopher; Miszczak‐Knecht, Maria; Kubuš, Peter; Bar‐Cohen, Yaniv; J. Kantoch, Michal; C. Thomas, Vincent; Hessling, Gabriele; M. Anderson, Christopher; Young, Ming‐Lon; H.J. Choi, Sally; Cabrera Ortega, Michel; R. Lau, Yung; L. Johnsrude, Christopher; Fournier, Anne; Van Petegem, Filip; Sanatani, Shubhayan

doi:10.1093/europace/euw389

Public

The clinical and genetic spectrum of catecholaminergic polymorphic ventricular tachycardia: findings from an international multicentre registry

Published in EP Europace • Nov 3, 2016

Authors:

Thomas M. Roston

Zhiguang Yuchi

Prince J. Kannankeril

Abstract

Aims: Catecholaminergic polymorphic ventricular tachycardia (CPVT) is an ion channelopathy characterized by ventricular arrhythmia during exertion or stress. Mutations in RYR2-coded Ryanodine Receptor-2 (RyR2) and CASQ2-coded Calsequestrin-2 (CASQ2) genes underlie CPVT1 and CPVT2, respectively. Howe...

Subject

Catecholaminergic polymorphic ventricular tachycardia

Medicine

Ventricular tachycardia

Research Assistant

AI chat, annotations, notes & similar papers

Finding related papers...

Discussions

(0)

No comments yet

Be the first to share your thoughts!